OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Allergy and Clinical Immunology is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Association between silicosis and autoimmune disease	50
Biologicals in IgE-mediated food allergy	32
The development of the DEFASE project	30
Updates in school-based asthma management	29
Food-labeling issues for severe food-allergic consumers	25
Occupational causes of chronic obstructive pulmonary disease: an update	23
MicroCrystalline Tyrosine-adsorbed immunotherapy	21
New molecules for atopic dermatitis treatment beyond biological therapy	21
Health disparities in allergic diseases	18
Antibody therapy for COVID-19	17
Endotypes of occupational asthma	17
Psychosocial impact of ocular surface allergic inflammatory disorders	15
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	15
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules	15
Editorial: Advances in drug hypersensitivity reactions	14
The use of environmental exposure chambers in studies related to ocular surface effects	13
SARS-CoV-2 vaccination in primary antibody deficiencies: an overview on efficacy, immunogenicity, durability of immune response and safety	13
Clinical outcomes of AIT in the elderly population	12
Management and treatment of perioperative hypersensitivity	12
Evaluating the glucagon-like peptide-1 receptor in managing asthma	12
The pathogenetic role of Th17 immune response in atopic dermatitis	12
Optimal use of intranasal corticosteroids and intranasal saline, is there a clear answer?	11
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	11
Coronavirus disease 2019 and severe asthma	11
Gene therapy for inborn error of immunity – current status and future perspectives	11

Advances in gene therapy for inborn errors of immunity	10
What molecular allergy teaches us about genetics and epidemiology of allergies	10
Role of biologics in severe food allergy	10
Clinical remission in severe asthma: lights and shadows on an ambitious goal	9
Anaphylaxis: glimpse into the future, attention to the present	9
The risk of anaphylaxis on holidays	9
Chronic urticaria: not only after COVID-19 vaccination	9
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency	9
Beyond the appearances: exploring complexities in anaphylaxis differential diagnosis	9
Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker	9
Atopic dermatitis endotypes: knowledge for personalized medicine	8
Exploring the management of recurrent angioedema caused by different mechanisms	8
Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies	8
New evidence in food allergies treatment	8
Understanding the heterogeneity of childhood allergic sensitization and its relationship with asthma	8
Moderate asthma: burden, mechanisms and therapeutic perspectives	8
Basophil activation test in food allergy: is it ready for real-time?	8
Classifying cephalosporins: from generation to cross-reactivity	8
Personalized management for unmet needs with food allergy	8
Social determinants of health and asthma	8
The role of type 2 diabetes in the severity of adult asthma	8
Role of the ocular surface microbiome in allergic eye diseases	7
Highlights of the treatment of allergic rhinitis according to Chinese guidelines	7
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	7
Biomarkers in the diagnosis of mast cell activation	7
Food allergy: new therapeutic options open deeper questions	7
Regulatory T-cells in asthma	6
The impact of obesity on immune function in pediatric asthma	6
The complexity in DNA methylation analysis of allergic diseases	6
Inborn errors of immunity underlying defective T-cell memory	6
Editorial introductions	6
Updates on treatment options in aspirin exacerbated respiratory disease	6
Editorial introductions	6
Editorial: Pharmacotherapy and evidence based medicine	6
Dietary strategies for the prevention of asthma in children	6
An update on patient reported outcomes in type 2 inflammation airway disease	6
Consequences of severe asthma exacerbations	6
Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma	5
E-cigarettes and asthma in adolescents	5
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis	5
Economic burden of drug-induced anaphylaxis: what can we do better?	5
Anaphylaxis due to antiallergic and antiasthmatic biologics	5
Editorial introductions	5
Anaphylaxis: unraveling the mysteries and new perspectives	5
Endotypic heterogeneity and pathogenesis in chronic rhinosinusitis	5
Is immunotherapy safe for treatment of severe asthma	5
Regular consumption following early introduction of allergenic foods and aggressive treatment of eczema are necessary for preventing the development of food allergy in children	5
Perspectives in the validation of DEFASE: a paradigm shift in food allergy management	5
Update on the use of allergen challenge chambers in immunotherapy: clinical implications	5
Editorial introductions	5

Air pollution and childhood asthma	5
Wood dust and asthma	5
Neurostimulation for dry eye disease	5
Long-term outcome of occupational asthma with different etiology	5